Replimune Group, Inc.REPLNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P9
Near historical low
vs 5Y Ago
-4.2x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -8.18% |
| Q3 2025 | 0.06% |
| Q2 2025 | 6.08% |
| Q1 2025 | 13.59% |
| Q4 2024 | 10.49% |
| Q3 2024 | 1.11% |
| Q2 2024 | 0.92% |
| Q1 2024 | -0.63% |
| Q4 2023 | -12.74% |
| Q3 2023 | 21.43% |
| Q2 2023 | 6.54% |
| Q1 2023 | 25.42% |
| Q4 2022 | 4.95% |
| Q3 2022 | -2.18% |
| Q2 2022 | 35.62% |
| Q1 2022 | 12.31% |
| Q4 2021 | -2.76% |
| Q3 2021 | 7.27% |
| Q2 2021 | 14.35% |
| Q1 2021 | 13.29% |
| Q4 2020 | 1.94% |
| Q3 2020 | 15.57% |
| Q2 2020 | 8.66% |
| Q1 2020 | -6.36% |
| Q4 2019 | 46.28% |
| Q3 2019 | 9.53% |
| Q2 2019 | 37.76% |
| Q1 2019 | -31.11% |
| Q4 2018 | 58.34% |
| Q3 2018 | 26.07% |
| Q2 2018 | -12.59% |
| Q1 2018 | 26.03% |
| Q4 2017 | 13.46% |
| Q3 2017 | 37.45% |
| Q2 2017 | -7.81% |
| Q1 2017 | 0.00% |